{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-24-000074","form_type":"8-K/A","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.438605+00:00","generated_at":"2026-05-31T13:22:54.098855+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Exagen appoints Jeffrey Black as CFO effective Sept 1, John Aballi interim CFO","bullets":["Kamal Adawi terminated as CFO and Corporate Secretary effective August 1, 2024.","John Aballi named interim CFO and principal financial officer pending Black's start.","Jeffrey Black to become CFO on Sept 1, 2024; base salary $460K, signing bonus $125K.","Black receives RSUs for 225,000 shares vesting over 4 years, target bonus 50% of salary."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-24-000074","json":"https://secwatch.observer/filing/0001274737-24-000074.json","markdown":"https://secwatch.observer/filing/0001274737-24-000074.md","text":"https://secwatch.observer/filing/0001274737-24-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000074/0001274737-24-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000074/exdx-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:22:54.098855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"021b0a298c","claim":"Jeffrey Black was appointed as Chief Financial Officer at EXAGEN INC..","evidence_excerpt":"On July 25, 2024, the Company appointed, effective as of September 1, 2024, Jeffrey Black to serve as the Company’s Chief Financial Officer and principal financial officer for SEC reporting purposes.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000074/0001274737-24-000074-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"1825489e59","claim":"Kamal Adawi departed as Chief Financial Officer and Corporate Secretary at EXAGEN INC..","evidence_excerpt":"replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000074/0001274737-24-000074-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"no longer serves"},{"label":"Role","value":"Chief Financial Officer and Corporate Secretary"}],"fact_type":"executive_change"},{"claim_id":"3d242b9a18","claim":"John Aballi was appointed as Interim Chief Financial Officer at EXAGEN INC..","evidence_excerpt":"the Company also announced that John Aballi had been appointed as Interim Chief Financial Officer of the Company, replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000074/0001274737-24-000074-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}